PALO ALTO—Vinita Kailasanath has joined Covington as a partner in the firm’s Life Sciences Transactions Practice Group and will be based in the firm’s Palo Alto office.
Vinita represents medtech and biotechnology companies, as well as multinational pharmaceutical companies, on complex licensing and collaboration deals, and advises on due diligence in connection with life sciences and technology M&A matters. Her practice focuses on strategic intellectual property and data-driven transactions and the development, commercialization, sourcing, and protection of new products and technologies, principally in the medtech and digital health industries.
“Vinita’s stellar reputation in life sciences transactions reflects her extensive industry knowledge spanning both life sciences and technology and her thoughtful and steadfast commitment to assisting clients across the West Coast life sciences ecosystem navigate their most important business transactions,” said John Hurvitz, co-chair of Covington’s global Life Sciences Practice and head of the firm’s Life Sciences Transactions Practice. “She will contribute additional strength to our leading Life Sciences Transactions Practice, enhancing how we support clients, ranging from emerging and growth‑stage companies navigating pivotal collaborations and licensing deals to more established companies executing complex strategic partnerships and platform deals. Her deep involvement in the medtech and biotech communities on the West Coast, and her broad experience with technology-driven transactions globally, are an exceptional fit with our practice.”
“I’m thrilled to join the firm and collaborate with such a talented group of lawyers,” Vinita said. “I look forward to further building and expanding the life sciences transactions and medtech practices, especially on the West Coast, and working with our clients to structure and negotiate their most high‑impact and innovative strategic transactions.”
Vinita received her B.A., M.A., and J.D. from Stanford University.
Back
